Recent articles















Is Aerie Pharmaceuticals a Buy?

The small-cap company's shares have fallen 64% in the last year, but a promising drug portfolio might signal an opportunity for investors with a long-term mindset.



Is Square a Buy?

The stock still hasn't recovered from a big fall back in August.